Product Image

Huperzine A 100 mcg

Source Naturals
4.6
★ ★ ★ ★ ★
(1619 ratings)
Huperzine 100 mcg
Product Image
Score85
A clearly sourced 100 mcg serving offers better flexibility than stronger Huperzine A options. It remains a narrow, long-acting cognitive ingredient that benefits from cautious scheduling.
How scoring works
Quantity:120 Tablet(s) • (120 servings)
Goals:
Productivity Boost
Cognitive Support
Brain Health
Mental Focus

Score 85

A clearly sourced 100 mcg serving offers better flexibility than stronger Huperzine A options. It remains a narrow, long-acting cognitive ingredient that benefits from cautious scheduling.
How scoring works
$16.06($0.13 per serving)
Pure Formulas
$ 16.07
Vitacost
$ 17.75
Amazon
$ 16.06
iHerb
$ 17.42
Report prices

Analysis

The 100 mcg amount provides a more conservative entry point than higher-potency Huperzine A products. Its Huperzia serrata leaf-extract source and exact active amount are both clearly disclosed.

Huperzine A may support short-term attention and memory through acetylcholine signaling. The formula remains narrow, however, and does not address mental energy, stress resilience, circulation, or structural brain support.

The lower amount offers better flexibility, but Huperzine A is still long acting. No cycling directions are included, so users must account for possible accumulation with frequent dosing.

Who is it for
  • First-time users seeking a lower Huperzine A amount
  • People who want focused short-term attention support
Best for
  • Flexible lower-dose Huperzine A use
  • Clear active and botanical-source disclosure

Pros

  • Provides a conservative 100 mcg amount
  • Identifies Huperzia serrata leaf extract
  • Single-active formula is easy to assess

Cons

  • No cycling guidance is provided
  • Covers only acetylcholine-related support
  • Not a broad daily brain-nutrition formula

Warnings

  • Huperzine A may cause nausea, dizziness, vivid dreams, muscle twitching, or a slowed heart rate.
  • Frequent use can allow cholinergic effects to accumulate despite the lower serving.
  • Acetylcholinesterase inhibitors and other cholinergic medicines may have stronger effects when combined with Huperzine A.

Nutrient quality

90 Highest impact

A precise huperzine A amount from a named leaf extract supports strong form quality. The moderate amount offers better flexibility, though cycling guidance remains important.

.

Ingredient transparency

83 Highest impact

The active amount and botanical source are disclosed without a hidden blend. Cycling guidance, complete directions, and inactive ingredients are not supplied.

.

Customer satisfaction

69 High impact

The supplied average rating is strong. A very large rating base makes the average dependable, but no detailed experience evidence was supplied.

.

Value for money

96 Highest impact

Serving economics are highly favorable. Formula quality supports the asking price well.

.
Report analysis

Goals

Productivity Boost
Impact
Highest effect
B+ Goal FitA+ Strength of SupportC- CoverageA+ Formula Quality
Huperzine · 100 mcg

Huperzine A directly increases acetylcholine signaling and may sharpen attention or memory acutely. The precise amount is within common supplemental use and the leaf-extract source is identified.

Its long activity makes continuous frequent use less suitable than cautious intermittent use. Cholinergic side effects can include nausea, vivid dreams, slowed heartbeat, or muscle twitching.

Study evidence
Huperzine No effect 1 study
Cognitive Support
Impact
Highest effect
B+ Goal FitA+ Strength of SupportC- CoverageA Formula Quality
Huperzine · 100 mcg

Huperzine A directly increases acetylcholine signaling and is well aligned with short-term memory and learning support. The precise 100 mcg amount and identified Huperzia serrata source provide unusually clear dosing.

Its narrow mechanism does not supply foundational membrane nutrients or broad stress and circulation support. Because Huperzine A remains active for an extended period, frequent use without cycling may increase nausea, dizziness, slow heart rate, or excessive cholinergic effects.

Study evidence
Huperzine Supportive 22 studies
Brain Health
Impact
Highest effect
A- Goal FitA Strength of SupportC- CoverageA+ Formula Quality
Huperzine · 100 mcg

Huperzine A directly raises acetylcholine signaling and is closely aligned with short-term memory and learning support. It is a potent acute nootropic rather than foundational long-term brain nutrition.

The 100 mcg amount is precise, well within common supplemental use, and fully disclosed. Frequent use may lead to accumulation because huperzine A remains active for a long time, increasing the chance of nausea, slow heart rate, or other cholinergic effects.

Study evidence
Huperzine Supportive 17 studies
Mental Focus
Impact
Highest effect
B+ Goal FitA Strength of SupportC- CoverageA Formula Quality
Huperzine · 100 mcg

Huperzine A directly raises acetylcholine activity and may provide noticeable short-term support for focus and memory. The precise 100 mcg amount fits a commonly used supplemental range.

Its narrow formula is easy to assess but does not cover mental energy or stress resilience. Because Huperzine A is long acting, frequent use or combination with cholinergic medicines can raise the risk of nausea, dizziness, or other excess-acetylcholine effects.

Study evidence
Huperzine Not classified

No linked studies yet.

Ingredients

IngredientAmount per serving
Huperzine A (Huperzia serrata Leaf Extract)
100 mcg
Gluten Free Adults 18–50 Dairy Free Sugar Free Women Vegetarian
Report overview
A+ Active Ingredient Quality & BioavailabilityA- Dose, Safety & Label TransparencyA+ Value

The tablet provides a precise, clearly disclosed Huperzine A serving from Huperzia serrata leaf extract. Its focused formula and efficient cost suit people who want Huperzine A without a broader stimulant blend. The available label details do not describe cycling, so frequent long-term use may increase exposure because Huperzine A remains active for an extended period.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. A phase II trial of huperzine A in mild to moderate Alzheimer disease.
    Rafii MS; Walsh S; Little JT; Behan K; Reynolds B; Ward C; Jin S; Thomas R; Aisen PS; Alzheimer's Disease Cooperative Study · Neurology · 2011
    Randomized trial210 participantsCognitive Support forHuperzine
  2. Effect of Huperzine A on Cognitive Function and Perception of Effort during Exercise: A Randomized Double-Blind Crossover Trial.
    Wessinger CM; Inman CL; Weinstock J; Weiss EP · International journal of exercise science · 2025
    Randomized trial15 participantsBrain Health Productivity Boost forHuperzine
  3. Huperzine A for vascular dementia.
    Hao Z; Liu M; Liu Z; Lv D · The Cochrane database of systematic reviews · 2009
    Systematic review14 participants1 studies pooledCognitive Support forHuperzine
  4. Pharmacotherapy for Vascular Cognitive Impairment.
    Farooq MU; Min J; Goshgarian C; Gorelick PB · CNS drugs · 2018
    Narrative reviewBrain Health forHuperzine
  5. Huperzine a in the treatment of Alzheimer's disease and vascular dementia: a meta-analysis.
    Xing SH; Zhu CX; Zhang R; An L · Evidence-based complementary and alternative medicine : eCAM · 2014
    Meta-analysis825 participants10 studies pooledBrain Health Cognitive Support forHuperzine
  6. Adjunctive huperzine A for cognitive deficits in schizophrenia: a systematic review and meta-analysis.
    Zheng W; Xiang YQ; Li XB; Ungvari GS; Chiu HF; Sun F; D'Arcy C; Meng X; Xiang YT · Human psychopharmacology · 2017
    Meta-analysis1,117 participants12 studies pooledCognitive Support forHuperzine
  7. Huperzine A associated with improved early postoperative cognitive function after neurosurgery under general anesthesia: a randomized clinical trial.
    Zhang Z; Shen Y; Li J; Tang Y; Zhou P; Ying T; Mo R; Ru Z; Zhao G; Zhu J; Li S; Zhao H · International journal of surgery (London, England) · 2026
    Randomized trial123 participantsCognitive Support Brain Health forHuperzine
  8. Treatment with Huperzine A improves cognition in vascular dementia patients.
    Xu ZQ; Liang XM; Juan-Wu; Zhang YF; Zhu CX; Jiang XJ · Cell biochemistry and biophysics · 2012
    Randomized trial78 participantsBrain Health forHuperzine
  9. [Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial].
    Zhang Z; Wang X; Chen Q; Shu L; Wang J; Shan G · Zhonghua yi xue za zhi · 2002
    Randomized trial202 participantsBrain Health Cognitive Support forHuperzine
  10. [Efficacy and safety of huperzine A in treating patients with mild cognitive impairment: a systematic review and Meta-analysis].
    Huang P; Li B; Guo YH; Feng S; Hu J; Liu QQ · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica · 2019
    Meta-analysis9 studies pooledBrain Health forHuperzine
  11. Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer's disease: an updated meta-analysis.
    Wang BS; Wang H; Wei ZH; Song YY; Zhang L; Chen HZ · Journal of neural transmission (Vienna, Austria : 1996) · 2009
    Meta-analysis4 studies pooledCognitive Support forHuperzine
  12. Huperzine A for Alzheimer's disease.
    Li J; Wu HM; Zhou RL; Liu GJ; Dong BR · The Cochrane database of systematic reviews · 2008
    Meta-analysis454 participants6 studies pooledCognitive Support forHuperzine
  13. Huperzine A for the treatment of cognitive, mood, and functional deficits after moderate and severe TBI (HUP-TBI): results of a Phase II randomized controlled pilot study: implications for understanding the placebo effect.
    Zafonte RD; Fregni F; Bergin MJG; Goldstein R; Boudreau N; Monge I; Luz M; Frazier J; Giacino JT · Brain injury · 2021
    Randomized trialBrain Health forHuperzine
  14. The effects of Huperzine A on dementia and mild cognitive impairment: An overview of systematic reviews.
    Ghassab-Abdollahi N; Mobasseri K; Dehghani Ahmadabad A; Nadrian H; Mirghafourvand M · Phytotherapy research : PTR · 2021
    Systematic review6 studies pooledBrain Health forHuperzine
  15. The treatment of cognitive dysfunction in dementia: a multiple treatments meta-analysis.
    Perng CH; Chang YC; Tzang RF · Psychopharmacology · 2019
    Meta-analysis44,854 participants235 studies pooledCognitive Support forHuperzine
  16. Huperzine-A response to cognitive impairment and task switching deficits in patients with Alzheimer's disease.
    Gul A; Bakht J; Mehmood F · Journal of the Chinese Medical Association : JCMA · 2019
    Randomized trial100 participantsBrain Health forHuperzine
  17. The effect of anti-dementia drugs on Alzheimer disease-induced cognitive impairment: A network meta-analysis.
    Cui CC; Sun Y; Wang XY; Zhang Y; Xing Y · Medicine · 2019
    Meta-analysis33 studies pooledCognitive Support forHuperzine
  18. [Drug evaluation of huperzine A in the treatment of senile memory disorders].
    Zhang RW; Tang XC; Han YY; Sang GW; Zhang YD; Ma YX; Zhang CL; Yang RM · Zhongguo yao li xue bao = Acta pharmacologica Sinica · 1992
    Randomized trial56 participantsCognitive Support forHuperzine